{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:54:11Z","timestamp":1791338051564,"version":"4.3.1"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T00:00:00Z","timestamp":1496188800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Acorda Therapeutics, Inc"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.nbd.2017.05.015","type":"journal-article","created":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T13:16:23Z","timestamp":1496236583000},"page":"142-155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination"],"prefix":"10.1016","volume":"105","author":[{"given":"Ariana P.","family":"Mullin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlene","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Troy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony O.","family":"Caggiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom J.","family":"Parry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond W.","family":"Colburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Pavlopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2017.05.015_bb0005","doi-asserted-by":"crossref","first-page":"8574","DOI":"10.1523\/JNEUROSCI.22-19-08574.2002","article-title":"Absence of fibroblast growth factor 2 promotes oligodendroglial repopulation of demyelinated white matter","volume":"22","author":"Armstrong","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2017.05.015_bb0010","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/135245859800400324","article-title":"A unique population of circulating autoantibodies promotes central nervous system remyelination","volume":"4","author":"Asakura","year":"1998","journal-title":"Mult. Scler."},{"key":"10.1016\/j.nbd.2017.05.015_bb0015","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/(SICI)1098-1136(199606)17:2<169::AID-GLIA8>3.0.CO;2-Y","article-title":"Expression of the APC tumor suppressor protein in oligodendroglia","volume":"17","author":"Bhat","year":"1996","journal-title":"Glia"},{"issue":"Suppl. 2","key":"10.1016\/j.nbd.2017.05.015_bb0020","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1177\/135245850000602S01","article-title":"Antibody-mediated remyelination: relevance to multiple sclerosis","volume":"6","author":"Bieber","year":"2000","journal-title":"Mult. Scler."},{"key":"10.1016\/j.nbd.2017.05.015_bb0025","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0165-5728(99)00083-1","article-title":"The origin of remyelinating cells in the central nervous system","volume":"98","author":"Blakemore","year":"1999","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2017.05.015_bb0030","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1007\/s00018-006-6094-7","article-title":"Myelin basic protein: a multifunctional protein","volume":"63","author":"Boggs","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.nbd.2017.05.015_bb0035","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1126\/science.285.5428.754","article-title":"Embryonic stem cell-derived glial precursors: a source of myelinating transplants","volume":"285","author":"Brustle","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.nbd.2017.05.015_bb0040","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1677\/JME-09-0067","article-title":"Cellular approaches to central nervous system remyelination stimulation: thyroid hormone to promote myelin repair via endogenous stem and precursor cells","volume":"44","author":"Calza","year":"2010","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.nbd.2017.05.015_bb0045","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1056\/NEJMoa010994","article-title":"Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis","volume":"346","author":"Chang","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2017.05.015_bb0055","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/jnr.23174","article-title":"Abbreviated exposure to cuprizone is sufficient to induce demyelination and oligodendrocyte loss","volume":"91","author":"Doan","year":"2013","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2017.05.015_bb0060","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.neuron.2010.01.027","article-title":"Dicer1 and miR-219 are required for normal oligodendrocyte differentiation and myelination","volume":"65","author":"Dugas","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2017.05.015_bb0065","doi-asserted-by":"crossref","first-page":"15694","DOI":"10.1523\/JNEUROSCI.3364-09.2009","article-title":"Transplanted neural precursors enhance host brain-derived myelin regeneration","volume":"29","author":"Einstein","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2017.05.015_bb0070","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.expneurol.2008.04.039","article-title":"Thyroid hormones promote differentiation of oligodendrocyte progenitor cells and improve remyelination after cuprizone-induced demyelination","volume":"212","author":"Franco","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2017.05.015_bb0075","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nrn2480","article-title":"Remyelination in the CNS: from biology to therapy","volume":"9","author":"Franklin","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2017.05.015_bb0080","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00415-008-1004-6","article-title":"The biology of CNS remyelination: the key to therapeutic advances","volume":"255","author":"Franklin","year":"2008","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2017.05.015_bb0085","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1056\/NEJMra052130","article-title":"Multiple sclerosis\u2014the plaque and its pathogenesis","volume":"354","author":"Frohman","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2017.05.015_bb0090","doi-asserted-by":"crossref","first-page":"6121","DOI":"10.1038\/ncomms7121","article-title":"The adhesion G protein-coupled receptor GPR56 is a cell-autonomous regulator of oligodendrocyte development","volume":"6","author":"Giera","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2017.05.015_bb0095","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.brainres.2009.06.005","article-title":"Regional differences between grey and white matter in cuprizone induced demyelination","volume":"1283","author":"Gudi","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2017.05.015_bb0100","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fncel.2014.00073","article-title":"Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned","volume":"8","author":"Gudi","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2017.05.015_bb0105","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3389\/fneur.2015.00257","article-title":"Remyelination therapy in multiple sclerosis","volume":"6","author":"Harlow","year":"2015","journal-title":"Front. Neurol."},{"key":"10.1016\/j.nbd.2017.05.015_bb0110","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.nbd.2009.10.016","article-title":"In toxic demyelination oligodendroglial cell death occurs early and is FAS independent","volume":"37","author":"Hesse","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2017.05.015_bb0115","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.nbd.2003.09.002","article-title":"Antiapoptotic signaling by a remyelination-promoting human antimyelin antibody","volume":"15","author":"Howe","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2017.05.015_bb0120","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/978-1-4615-4685-6_15","article-title":"The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination","volume":"468","author":"Keirstead","year":"1999","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.nbd.2017.05.015_bb0125","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00401-009-0591-3","article-title":"The cuprizone animal model: new insights into an old story","volume":"118","author":"Kipp","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2017.05.015_bb0130","first-page":"186","article-title":"Blood\u2013brain barrier permeability to horseradish peroxidase in twitcher and cuprizone-intoxicated mice","author":"Kondo","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2017.05.015_bb0135","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1093\/brain\/awn096","article-title":"Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis","volume":"131","author":"Kuhlmann","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2017.05.015_bb0140","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2990.2007.00879.x","article-title":"Sequential myelin protein expression during remyelination reveals fast and efficient repair after central nervous system demyelination","volume":"34","author":"Lindner","year":"2008","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.nbd.2017.05.015_bb0145","doi-asserted-by":"crossref","first-page":"6126","DOI":"10.1073\/pnas.97.11.6126","article-title":"Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation","volume":"97","author":"Liu","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2017.05.015_bb0150","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.it.2008.10.002","article-title":"Naturally occurring auto-antibodies in homeostasis and disease","volume":"30","author":"Lutz","year":"2009","journal-title":"Trends Immunol."},{"key":"10.1016\/j.nbd.2017.05.015_bb0155","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/1097-4547(20000801)61:3<251::AID-JNR3>3.0.CO;2-W","article-title":"Mature oligodendrocyte apoptosis precedes IGF-1 production and oligodendrocyte progenitor accumulation and differentiation during demyelination:remyelination","volume":"61","author":"Mason","year":"2000","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2017.05.015_bb0160","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0002-9440(10)63726-1","article-title":"Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions","volume":"164","author":"Mason","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.nbd.2017.05.015_bb0165","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1750-3639.2001.tb00385.x","article-title":"The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system","volume":"11","author":"Matsushima","year":"2001","journal-title":"Brain Pathol."},{"key":"10.1016\/j.nbd.2017.05.015_bb0170","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/npp.2008.145","article-title":"In vitro and in vivo pharmacological models to assess demyelination and remyelination","volume":"34","author":"Merrill","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nbd.2017.05.015_bb0175","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.21581","article-title":"Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells","volume":"65","author":"Mi","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2017.05.015_bb0180","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/nn1995","article-title":"Dissecting demyelination","volume":"10","author":"Miller","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2017.05.015_bb0185","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.bbadis.2010.09.010","article-title":"Cells of the oligodendroglial lineage, myelination, and remyelination","volume":"1812","author":"Miron","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2017.05.015_bb0190","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1096\/fj.01-0994fje","article-title":"Direct evidence that a human antibody derived from patient serum can promote myelin repair in a mouse model of chronic-progressive demyelinating disease","volume":"16","author":"Mitsunaga","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.nbd.2017.05.015_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011769","article-title":"Effects of fumaric acids on cuprizone induced central nervous system de- and remyelination in the mouse","volume":"5","author":"Moharregh-Khiabani","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2017.05.015_bb0200","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1523\/JNEUROSCI.4502-13.2014","article-title":"Local regulation of neurofilament transport by myelinating cells","volume":"34","author":"Monsma","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2017.05.015_bb0205","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrn2495","article-title":"Polydendrocytes (NG2 cells): multifunctional cells with lineage plasticity","volume":"10","author":"Nishiyama","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2017.05.015_bb0210","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.cell.2011.09.056","article-title":"Neuralized1 activates CPEB3: a function for nonproteolytic ubiquitin in synaptic plasticity and memory storage","volume":"147","author":"Pavlopoulos","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2017.05.015_bb0215","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S1044-7431(02)00018-0","article-title":"Remyelination-promoting antibodies activate distinct Ca2+ influx pathways in astrocytes and oligodendrocytes: relationship to the mechanism of myelin repair","volume":"22","author":"Paz Soldan","year":"2003","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2017.05.015_bb0220","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1096\/fj.04-2026fje","article-title":"A human antibody that promotes remyelination enters the CNS and decreases lesion load as detected by T2-weighted spinal cord MRI in a virus-induced murine model of MS","volume":"18","author":"Pirko","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.nbd.2017.05.015_bb0225","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.3390\/brainsci3031282","article-title":"Myelin recovery in multiple sclerosis: the challenge of remyelination","volume":"3","author":"Podbielska","year":"2013","journal-title":"Brain Sci."},{"issue":"Issue 4","key":"10.1016\/j.nbd.2017.05.015_bb0230","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0092-8674(87)90249-2","article-title":"Myelin deficient mice- Expression of myelin basic protein and generation of mice with varying levels of myelin","volume":"48","author":"Popko","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2017.05.015_bb0235","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.neubiorev.2014.10.004","article-title":"Cellular and molecular neuropathology of the cuprizone mouse model: clinical relevance for multiple sclerosis","volume":"47","author":"Praet","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.nbd.2017.05.015_bb0240","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00005072-199305000-00003","article-title":"Multiple sclerosis: remyelination in acute lesions","volume":"52","author":"Raine","year":"1993","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2017.05.015_bb0245","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/nn.3168","article-title":"Animal models of multiple sclerosis: the good, the bad and the bottom line","volume":"15","author":"Ransohoff","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2017.05.015_bb0250","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4103\/2277-9175.151570","article-title":"Neurotrophic factors and their effects in the treatment of multiple sclerosis","volume":"4","author":"Razavi","year":"2015","journal-title":"Adv. Biomed. Res."},{"key":"10.1016\/j.nbd.2017.05.015_bb0255","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0092-8674(87)90248-0","article-title":"Expression of a myelin basic protein gene in transgenic shiverer mice- correction of the dysmyelinating phenotype","volume":"48","author":"Readhead","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2017.05.015_bb0260","doi-asserted-by":"crossref","DOI":"10.1177\/1759091414551955","article-title":"A new model of cuprizone-mediated demyelination\/remyelination","volume":"6","author":"Sachs","year":"2014","journal-title":"ASN Neuro"},{"key":"10.1016\/j.nbd.2017.05.015_bb0265","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nm.3495","article-title":"Label-free in vivo imaging of myelinated axons in health and disease with spectral confocal reflectance microscopy","volume":"20","author":"Schain","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2017.05.015_bb0270","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s12031-012-9896-0","article-title":"Regional heterogeneity of cuprizone-induced demyelination: topographical aspects of the midline of the corpus callosum","volume":"49","author":"Schmidt","year":"2013","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.nbd.2017.05.015_bb0275","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.bbi.2011.05.009","article-title":"Lipopolysaccharide delays demyelination and promotes oligodendrocyte precursor proliferation in the central nervous system","volume":"25","author":"Skripuletz","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.nbd.2017.05.015_bb0280","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0301-0082(02)00105-3","article-title":"Remyelinating strategies for the treatment of multiple sclerosis","volume":"68","author":"Stangel","year":"2002","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2017.05.015_bb0285","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.neures.2011.10.002","article-title":"Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication","volume":"72","author":"Steelman","year":"2012","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.nbd.2017.05.015_bb0290","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1750-3639.2003.tb00032.x","article-title":"Uantifying the early stages of remyelination following cuprizone-induced demyelination","volume":"13","author":"Stidworthy","year":"2003","journal-title":"Brain Pathol."},{"key":"10.1016\/j.nbd.2017.05.015_bb0295","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/jdb4030028","article-title":"Hedgehog: a key signaling in the development of the oligodendrocyte lineage","volume":"4","author":"Traiffort","year":"2016","journal-title":"J. Dev. Biol."},{"key":"10.1016\/j.nbd.2017.05.015_bb0300","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev.neuro.30.051606.094313","article-title":"Multiple sclerosis: an immune or neurodegenerative disorder?","volume":"31","author":"Trapp","year":"2008","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2017.05.015_bb0305","doi-asserted-by":"crossref","first-page":"14182","DOI":"10.1523\/JNEUROSCI.6595-10.2011","article-title":"Levels of BDNF impact oligodendrocyte lineage cells following a cuprizone lesion","volume":"31","author":"VonDran","year":"2011","journal-title":"J. Neurosci."},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2017.05.015_bb0310","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1007\/s10875-010-9406-5","article-title":"Method of identifying natural antibodies for remyelination","volume":"30","author":"Warrington","year":"2010","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.nbd.2017.05.015_bb0315","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.1073\/pnas.97.12.6820","article-title":"Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis","volume":"97","author":"Warrington","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2017.05.015_bb0320","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/jnr.21217","article-title":"A recombinant human IgM promotes myelin repair after a single, very low dose","volume":"85","author":"Warrington","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2017.05.015_bb0325","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.neuron.2008.09.011","article-title":"Distinct stages of myelination regulated by gamma-secretase and astrocytes in a rapidly myelinating CNS coculture system","volume":"60","author":"Watkins","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2017.05.015_bb0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055149","article-title":"PDGF is required for remyelination-promoting IgM stimulation of oligodendrocyte progenitor cell proliferation","volume":"8","author":"Watzlawik","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2017.05.015_bb0335","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-015-9436-3","article-title":"Antibody-mediated oligodendrocyte remyelination promotes axon health in progressive demyelinating disease","author":"Wootla","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2017.05.015_bb0340","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/NEN.0b013e3181e3de90","article-title":"Rostrocaudal analysis of corpus callosum demyelination and axon damage across disease stages refines diffusion tensor imaging correlations with pathological features","volume":"69","author":"Xie","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2017.05.015_bb0345","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003462","article-title":"Npc1 acting in neurons and glia is essential for the formation and maintenance of CNS myelin","volume":"9","author":"Yu","year":"2013","journal-title":"PLoS Genet."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996117301249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996117301249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:12:40Z","timestamp":1760850760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996117301249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":68,"alternative-id":["S0969996117301249"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2017.05.015","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2017.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}